Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/05/2026 | Q4 | $499M | -- | -- | $1.30 | -- |
| 11/06/2025 | Q3 | $498.8M | $513.7M | $1.31 | $1.57 | -$0.26 |
| 08/06/2025 | Q2 | $499M | $498.7M | $1.43 | $1.39 | $0.04 |
| 05/08/2025 | Q1 | $477M | $476.6M | $1.25 | $1.20 | $0.05 |
| 03/06/2025 | Q4 | $447M | $470.9M | $1.29 | $0.89 | $0.40 |
| 11/04/2024 | Q3 | $443M | $472.9M | $1.27 | $0.95 | $0.32 |
| 08/08/2024 | Q2 | $434M | $445.6M | $1.00 | $0.80 | $0.20 |
| 05/08/2024 | Q1 | $412M | $412.6M | $0.67 | $0.71 | -$0.04 |
| 03/07/2024 | Q4 | $411M | $407M | $0.94 | $0.36 | $0.58 |
| 11/09/2023 | Q3 | -- | $419.2M | $0.93 | -- | -- |
| 08/08/2023 | Q2 | -- | $428M | $1.05 | -- | -- |
| 05/11/2023 | Q1 | -- | $424.3M | $0.95 | -- | -- |
| 03/24/2023 | Q4 | -- | $406.3M | $0.37 | -- | -- |
| 11/09/2022 | Q3 | -- | $387.3M | $0.71 | -- | -- |
| 08/08/2022 | Q2 | -- | $367.8M | $0.74 | -- | -- |
| 05/10/2022 | Q1 | -- | $319.4M | $0.65 | -- | -- |
| 03/25/2022 | Q4 | -- | $293.1M | $0.04 | -- | -- |
| 12/08/2021 | Q3 | -- | $289.5M | $0.36 | -- | -- |
| 08/06/2021 | Q2 | -- | $285.7M | $0.40 | -- | -- |
| 05/07/2021 | Q1 | -- | $245.6M | $0.02 | -- | -- |
| 03/09/2021 | Q4 | -- | $232.7M | -$0.13 | -- | -- |
| 11/06/2020 | Q3 | -- | $220.2M | -$1.95 | -- | -- |
| 08/06/2020 | Q2 | -- | $251.4M | $0.13 | -- | -- |
| 05/08/2020 | Q1 | -- | $301M | $0.33 | -- | -- |
| 03/06/2020 | Q4 | -- | $293.1M | $0.18 | -- | -- |
| 11/06/2019 | Q3 | -- | $327.2M | $0.71 | -- | -- |
| 08/06/2019 | Q2 | -- | $333.3M | $0.73 | -- | -- |
| 05/07/2019 | Q1 | -- | $311.2M | $0.39 | -- | -- |
| 03/07/2019 | Q4 | -- | $311M | $0.60 | -- | -- |
| 11/05/2018 | Q3 | -- | $308M | $0.46 | -- | -- |
| 08/07/2018 | Q2 | -- | $311.2M | $0.63 | -- | -- |
| 05/08/2018 | Q1 | -- | $285.9M | $0.24 | -- | -- |
| 03/20/2018 | Q4 | -- | $265.6M | $0.36 | -- | -- |
| 11/02/2017 | Q3 | -- | $251.9M | $0.16 | -- | -- |
| 07/25/2017 | Q2 | -- | $250.7M | $0.23 | -- | -- |
| 03/31/2017 | Q1 | -- | $238.5M | $0.17 | -- | -- |
| 03/31/2017 | Q4 | -- | $222.3M | $0.42 | -- | -- |
| 11/07/2016 | Q3 | -- | $230M | $0.02 | -- | -- |
| 08/09/2016 | Q2 | -- | $256.2M | $0.34 | -- | -- |
| 05/13/2016 | Q1 | -- | $253.6M | -$0.35 | -- | -- |
| 02/26/2016 | Q4 | -- | $278.7M | -$0.20 | -- | -- |
DXP Enterprises, Inc. reported $513.7M worth of top line sales in its most recent quarter.
DXP Enterprises, Inc. announced earnings per share of $1.31 which represents a miss of analyst forecast a $1.57 per share.
DXP Enterprises, Inc. reported $161.3M that represents $9.76 per share over the last quarter.
DXP Enterprises, Inc.'s earnings are forecast to grow from $4.22 per share to $4.07 per share next year representing an increase of 26.44%.
DXP Enterprises, Inc.'s next earnings date is March 5, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.